Sensata Technologies Appoints John Mirshekari to Its Board of Directors

SWINDON, England–(BUSINESS WIRE)–Sensata Technologies Holding plc (NYSE: ST) today announced that John Mirshekari has been appointed to Sensata’s Board of Directors and to serve on the Growth & Innovation Committee and the Finance Committee, effective March 1, 2024. “John brings decades of experience in business strategy, shareholder value creation and corporate governance, as well as an institutional investor”Post this Mr. Mirshekari brings more than two … Continue reading Sensata Technologies Appoints John Mirshekari to Its Board of Directors

Impact Newswire23/02/202423/02/2024

Europe, Global

New Global Manager Appointed to Lincotek Surface Solutions Division

Angelo Parente Tasked With Driving Further Growth RUBBIANO, PARMA, Italy–(BUSINESS WIRE)–Lincotek has announced today the appointment of Angelo Parente as new Global General Manager of its Surface Solutions Division – a global provider of fully integrated supply chain solutions for the Energy and Aerospace markets. Angelo will take over the role from February 22nd, 2024. “There are many opportunities ahead for the Surface Solutions Division and I’m looking forward to delivering on … Continue reading New Global Manager Appointed to Lincotek Surface Solutions Division

Impact Newswire22/02/202422/02/2024

Global, United States

Jessica Ringena Named President of Amber Specialty Pharmacy

OMAHA, Neb.–(BUSINESS WIRE)–Amber Specialty Pharmacy announces the appointment of Jessica Ringena as its newest president. Ringena previously served as president of Vivid Clear Rx, a pharmacy benefit manager and subsidiary of Hy-Vee. Known for her strategic leadership in health care, technology, finance and innovation, Ringena will lead the specialty pharmacy in its mission to deliver personalized care to patients who experience chronic and complex conditions. … Continue reading Jessica Ringena Named President of Amber Specialty Pharmacy

Impact Newswire22/02/202422/02/2024

Europe, Global

MMI Raises $110 Million in Series C Financing

Largest ever investment in microsurgery will further MMI’s mission to transform open surgery with robotic technology JACKSONVILLE, Fla.–(BUSINESS WIRE)–MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it has raised $110 million in Series C financing. The round, led by Fidelity Management & Research Company, marks the largest ever investment in … Continue reading MMI Raises $110 Million in Series C Financing

Impact Newswire21/02/202421/02/2024

Global, United States

ZincFive Earns Finalist Spot in Esteemed 2024 Edison Awards™

Nickel-zinc battery technology earns industry excellence recognition in Resilient & Sustainable Solutions category PORTLAND, Ore.–(BUSINESS WIRE)–ZincFive®, the world leader in nickel-zinc (NiZn) battery-based solutions for immediate power applications, has been named a finalist in the 2024 Edison Awards™. The company is being honored in the Resilient & Sustainable Solutions category for its safe, reliable, powerful and sustainable nickel-zinc battery technology. @ZincFiveInc’s safe, reliable, powerful and sustainable … Continue reading ZincFive Earns Finalist Spot in Esteemed 2024 Edison Awards™

Impact Newswire20/02/202420/02/2024

Global, United States

Julius Genachowski and Dawn Ostroff Join Mattel Board of Directors

Mr. Genachowski previously served as Chairman of the FCC; Ms. Ostroff was Chief Content & Advertising Business Officer at Spotify EL SEGUNDO, Calif.–(BUSINESS WIRE)–Mattel, Inc. (NASDAQ: MAT) announced today that Julius Genachowski and Dawn Ostroff have joined the Company’s Board of Directors, effective February 5, 2024. The new Directors bring extensive combined experience in media, entertainment, and technology, and expertise in finance, M&A, and government … Continue reading Julius Genachowski and Dawn Ostroff Join Mattel Board of Directors

Impact Newswire15/02/202415/02/2024

Global, United States

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

— Gilead Adds Seladelpar to Portfolio, a PPARδ Agonist for the Treatment of Primary Biliary Cholangitis (PBC) with FDA Priority Review and Anticipated U.S. Approval in Third Quarter of 2024 — — Seladelpar Phase 3 Data Demonstrates a Best-in-Disease Profile for Second-Line PBC — — Acquisition Expands Gilead’s Long-Standing Commitment to Patients with Liver Diseases — February 12, 2024 08:30 AM Eastern Standard Time FOSTER … Continue reading Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Impact Newswire13/02/202413/02/2024

Global, United States

AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Global executive will lead the clinical research strategy and execution for pulse intravascular lithotripsy BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs. She comes to AVS with more than two decades of leadership experience … Continue reading AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Impact Newswire08/02/202408/02/2024

Global, United States

Cargill becomes first global edible oils supplier to meet World Health Organization’s best practice on eliminating industrially produced trans-fatty acids

Meets 2021 commitment; removes iTFA from fats and oils even in countries without legislative mandates MINNEAPOLIS–(BUSINESS WIRE)–As of Jan. 1, 2024, every Cargill food customer, no matter where they are in the world, can be confident that the company’s fats and oils comply with the World Health Organization’s (WHO) recommended maximum tolerance level for industrially produced trans-fatty acids (iTFA) in fats and oils. Cargill has … Continue reading Cargill becomes first global edible oils supplier to meet World Health Organization’s best practice on eliminating industrially produced trans-fatty acids

Impact Newswire05/02/202405/02/2024